AMRZ vs CX: Amrize and Cemex SAB de CV ADR compared
The short version
From the latest prices and each company's SEC filings. Who's ahead on each measure, not which to buy.
- Amrize is the larger company, worth $19.3B, about 1.5 times Cemex SAB de CV ADR.
- Amrize grew revenue faster over the last year (+8.6% vs -2.1%).
- Amrize keeps more of each dollar of revenue as operating profit (15.5% vs 11.2%).
- On earnings, Amrize is the cheaper stock (16.7x vs 478.0x).
- Cemex SAB de CV ADR's price assumes faster free cash flow growth: about 6% a year, against -0% for Amrize (reverse DCF).
Side by side
The stronger figure is shaded where higher (or, for valuation multiples, lower) reads as better. How the implied growth works.
| Measure | AMRZ | CX |
|---|---|---|
| Market cap | $19.3B | $13.2B |
| Share price | $36.20 | $9.56 |
| Revenue (last fiscal year) | $11.8B | $16.2B |
| Free cash flow (last fiscal year) | $1.4B | $598M |
| Revenue growth, last year | +8.6% | -2.1% |
| Revenue growth per year, last 5 fiscal years | +0.6% | +6.3% |
| Operating margin | 15.5% | 11.2% |
| Net margin | 10.0% | 5.8% |
| Return on equity | 9.4% | 7.7% |
| P/E (trailing) | 16.7x | 478.0x |
| Price / free cash flow | 13.6x | 13.1x |
| EV / EBITDA | 9.51x | 8.72x |
| FCF growth the price implies | -0.06% | 6.3% |
| Dividend yield | 1.2% | 0.98% |
| Debt / equity | 0.91x | 1.22x |
| Fundamental grade | C | C |
| Superinvestors holding it | 7 | 4 |
| Insider purchases, last 12 months | 10 | 1 |
Results from SEC filings
Revenue and free cash flow by fiscal year, from each company's 10-K filings.
Amrize
| Year | Revenue | Free cash flow | Op. margin |
|---|---|---|---|
| 2023 | $11.7B | $1.4B | 16.2% |
| 2024 | $11.7B | $1.6B | 18.8% |
| 2025 | $11.8B | $1.4B | 16.1% |
Cemex SAB de CV ADR
| Year | Revenue | Free cash flow | Op. margin |
|---|---|---|---|
| 2020 | $12.7B | $1.0B | -3.7% |
| 2021 | $14.4B | $875M | 11.4% |
| 2022 | $14.7B | $462M | 5.9% |
| 2023 | $16.6B | $1.1B | 10.6% |
| 2024 | $16.2B | $598M | 11.2% |
Where the revenue comes from
Amrize · by segments, 2025
Building Materials$8.5B72%
Building Envelope$3.3B28%
Cemex SAB de CV ADR · by segments, 2025
Reportable segments$15.5B96%
All other segments$641M4%
Compare them in fullFifteen years of statements, quarterly results, DCF and IRR models, and any number of peers side by side.
Open AMRZ in InvestinglyQuestions
Which is bigger, Amrize or Cemex SAB de CV ADR?
Amrize (AMRZ), at $19.3B against $13.2B.
Is AMRZ or CX cheaper?
By trailing P/E, Amrize (16.7x) is cheaper than Cemex SAB de CV ADR (478.0x). A lower multiple can also mean the market expects less growth.
Which grows faster, AMRZ or CX?
Amrize: revenue grew +8.6% over the last year, against -2.1%.
Prices and ratios as of the last daily update; statements from SEC filings. Information only, not investment advice.